Trials / Withdrawn
WithdrawnNCT00814112
Glycosaminoglycans During Septic Shock - a Temporal Study
GAGS - Glykosaminoglykaner Vid Sepsis
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
We have previously shown that the plasma level of glycosaminoglycans (GAG) in septic shock patients are elevated compared to controls. The purpose of this study is to investigate the temporal dynamic of the blood level of GAG in ten septic shock patients. In addition, to assess the kinetics of GAG during septic shock we examine the liver function by galactose elimination capacity as well as excreted urinary GAG.
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2008-12-23
- Last updated
- 2024-03-15
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00814112. Inclusion in this directory is not an endorsement.